Amyotrophic lateral sclerosis and Alzheimer's disease. Lessons from model systems

Revue Neurologique

Volumn 153, Issue 8-9, 1997, Pages 484-495

  Price, D L ^a   Wong, P C ^a   Borchelt, D R ^a   Pardo, C A ^a   Thinakaran, G ^a   Doan, A P ^a   Lee, M K ^a   Martin, L J ^a   Sisodia, S S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ARTICLE; CYTOSKELETON; GENE MUTATION; MOTOR NEURON DISEASE; NONHUMAN; PATHOPHYSIOLOGY;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; DOGS; HUMANS; MICE; MICE, TRANSGENIC;

EID: 0030809603     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (145)

1. ANDERSON A.J., Su J.H., COTMAN C.W. (1996). DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 16 : 1710-1719.
2. ARNOLD S.E., HYMAN B.T., FLORY J., DAMASIO A.R., VAN HOESEN G.W. (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1 : 103-116.
3. BACHEVALIER J., LANDIS L.S., WALKER L.C., BRICKSON M., MISHKIN M., PRICE D.L., CORK L.C. (1991). Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction. Neurobiol Aging 12 : 99-111.
4. BEAL M.F., WALKER L.C., STOREY E., SEGAR L., PRICE D.L., CORK L.C. (1991). Neurotransmitters in neocortex of aged rhesus monkeys. Neurobiol Aging 12 : 407-412.
5. BECKMAN J.S., CARSON M., SMITH C.D., KOPPENOL W.H. (1993). ALS, SOD and peroxynitrite. Nature 364 : 584
6. BORCHELT D.R., LEE M.K., SLUNT H.H., GUARNIERI M., Xu Z.-S., WONG P.C., BROWN R.H., JR., PRICE D.L., SISODIA S.S., CLEVELAND D.W. (1994). Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91 : 8292-8296.
7. BORCHELT D.R., GUARNIERI M., WONG P.C., LEE M.K., SLUNT H.S., Xu Z., SISODIA S.S., PRICE D.L., CLEVELAND D.W. (1995). Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J Biol Chem 270 : 3234-3238.
8. BORCHELT D.R., THINAKARAN G., ECKMAN C.B., LEE M.K., DAVENPORT F., RATOVITSKY T., PRADA C.-M., KIM G., SEEKINS S., YAGER D., SLUNT H.H., WANG R., SEEGER M., LEVEY A.I., GANDY S.E., COPELAND N.G., JENKINS N.A., PRICE D.L., YOUNKIN S.G., SISODIA S.S. (1996a). Familial Alzheimer's disease-linked presenilin 1 variants elevate Aß1-42/1-40 ratio in vitro and in vivo. Neuron 17 : 1005-1013.
9. BORCHELT D.R., WONG P.C., BECHER M.W., PARDO C.A., LEE M.K., Xu Z.-S., THINAKARAN G., JENKINS N.A., COPELAND N.G., SISODIA S.S., CLEVELAND D.W., PRICE D.L., HUFFMAN P.N. Early axonal abnormalities and axonal transport of mutant Superoxide dismutase 1 in a transgenic model of familial amyotrophic lateral sclerosis. J Neumsci, in press.
10. BRAAK H., BRAAK E. (1994). In Calne DB (ed.), Pathology of Alzheimer's disease, pp. 585-613. W.B. Saunders, Philadelphia.
11. BRION J.-P. (1990). Molecular pathology of Alzheimer amyloid and neurofibrillary tangles. Semin Neurosci 2 : 89-100.
12. BURRIGHT E.N., CLARK H.B., SERVADIO A., MATILLA T., FEDDERSEN R.M., YUNIS W.S., DUVICK L.A., ZOGHBI H.Y., ORR HT. (1995). SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82 : 937-948.
13. BUSCIGLIO J., LORENZO A., YEH J., YANKNER B.A. (1995). ß-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14 : 879-888.
14. CAI X.-D., GOLDE T.E., YOUNKIN S.O. (1993). Release of excess amyloid ß protein from a mutant amyloid á protein precursor. Science 259 : 514-516.
15. CARPENTER S. (1968). Proximal axonal enlargement in motor neuron disease. Neurology 18 : 841-851.
16. CHARTIER-HARLIN M.-C., CRAWFORD F., HOULDEN H., WARREN A., HUGHES D., Fidani L., Goate A., ROSSOR M., ROQUES P., HARDY J., MULLAN M. (1991). Early-onset Alzheimer's disease caused by mutations at codon 717 of the ß-amyloid precursor protein gene. Nature 353 : 844-846.
17. CITRON M., OLTERSDORF T., HAASS C., MCCONLOGUE L., HUNG A.Y., SEUBERT P., VIGO-PELFREY C., LIEBERBURG I., SELKOE D.J. (1992). Mutation of the ß-amyloid precursor protein in familial Alzheimer's disease increases ß-protein production. Nature 360 : 672-674.
18. CLARK A.W., GRIFFIN J.W., PRICE D.L. (1980). The axonal pathology in chronic IDPN intoxication. J Neuropathol Exp Neurol 39 : 42-55.
19. CLATTERBUCK R.E., PRICE D.L., KOLIATSOS V.E. (1994). Further characterization of the effects of brain-derived neurotrophic factor and ciliary neurotrophic factor on axotomized neonatal and adult mammalian motor neurons. J Comp Neurol 342 : 45-56.
20. COLLARD J.-F., CÔTÉ F., JULIEN J.-P. (1995). Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375 : 61-64.
21. CORDER E.H., SAUNDERS A.M., STRITTMATTER W.J., SCHMECHEL D.E., GASKELL P.C., SMALL G.W., ROSES A.D., HAINES J.L., PERICAK-VANCE M.A. (1993). Gene dose of apolipoprotein-E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 : 921-923.
22. CORK L.C., GRIFFIN J.W., MUNNELL J.F., LORENZ M.D., ADAMS R.J., PRICE D.L. (1979). Hereditary canine spinal muscular atrophy. J Neuropathol Exp Neurol 38 : 209-221.
23. CORK L.C., GRIFFIN J.W., CHOY C., PADULA C.A., PRICE D.L. (1982). Pathology of motor neurons in accelerated Hereditary Canine Spinal Muscular Atrophy. Lab Invest 46 : 89-99.
24. CORK L.C., TRONCOSO J.C., PRICE D.L., STANLEY E.F., GRIFFIN J.W. (1983). Canine neuroaxonal dystrophy. J Neuropathol Exp Neurol 42 : 286-296.
25. CORK L.C., ALTSCHULER R.J., BRUHA P.J., MORRIS J.M., LLOYD D.G., LOATS H.L., GRIFFIN J.W., PRICE D.L. (1989a). Changes in neuronal size and neurotransmitter marker in Hereditary Canine Spinal Muscular Atrophy. Lab Invest 61 : 69-76.
26. CORK L.C., STRUBLE R.G., GOLD E.G., DICARLO C., FAHNESTOCK K.E., GRIFFIN J.W., PRICE D.L. (1989b). Changes in size of motor axons in Hereditary Canine Spinal Muscular Atrophy. Lab Invest 61 : 333-342.
27. CORK L.C., MASTERS C., BEYREUTHER K., PRICE D.L. (1990). Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits. Am J Pathol 137 : 1383-1392.
28. COTMAN C.W., PIKE C.J. (1994). In Terry RD, Katzman R, and Bick KL (eds.), ß-amyloid and its contributions to neurodegeneration in Alzheimer disease, pp. 305-315. Raven Press, New York.
29. CÔTÉ F., COLLARD J.-F., JULIEN J.-P. (1993). Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell, 73 : 35-46.
30. DAL CANTO M.C., GURNEY M.E. (1994a). Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol, 145 : 1271-1280.
31. DAL CANTO M.C., GURNEY M.E. (1994b). The development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol, 145 : 1-9.
32. DAL CANTO M.C., GURNEY M.E. (1995). Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,ZN SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res, 676 : 25-40.
33. DENG H.-X., HENTATI A., TAINER J.A., IQBAL Z., CAYABYAB A., HUNG W.-Y., GETZOFF E.D., Hu P., HERZFELDT B., Roos R.P., WARNER C., DENG G, SORIANO E, SMYTH C, PARGE HE, AHMED A, ROSES AD, HALLEWELL R.A., PERICAK-VANCE M.A., SIDDIQUE T. (1993). Amyotrophic lateral sclerosis and structural defects in Cu,Zn Superoxide dismutase. Science, 261 : 1047-1051.
34. DOAN A., THINAKARAN G., BORCHELT D.R., SLUNT H.H., RATOVITSKY T., PODLISNY M., SELKOE D.J., SEEGER M., GANDY S.E., PRICE D.L., SISODIA S.S. (1996). Protein topology of presenilin 1. Neuron 17 : 1023-1030.
35. ESCH F.S., KEIM P.S., BEATTIE E.C., BLACHER R.W., CULWELL A.R., OLTERSDORF T., MCCIURE D., WARD P.J. (1990). Cleavage of amyloid ß peptide during constitutive processing of its precursor. Science, 248 : 1122-1124.
36. FHIDOVICH I. (1986). Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol, 58 : 61-97.
37. GAMES D., ADAMS D., ALESSANDRINI R., BARBOUR R., BERTHELETTE P., BLACKWELL C., CARR T., CLEMENS J., DONALDSON T., GILLESPIE F., GUIDO T., HAGOPIAN S., JOHNSON-WOOD K., KHAN K., LEE M., LEIBOWITZ P., LIEBERBURG I., LITTLE S., MASLIAH E., MCCONLOGUE L., MONTOYA-ZAVALA M., MUCKE L., PAGANINI L., PENNIMAN E., POWER M., SCHENK D., SEUBERT P., SNYDER B., SORIANO F., TAN H., VITALE J., WAOSWORTH S., WOLOZIN B., ZHAO J. (1995). Alzheimertype neuropathology in transgenic mice overexpressing V717F ß-amyloid precursor protein. Nature, 373 : 523-527.
38. GLENNER G.G., WONG C.W. (1984a). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun, 120 : 885-890.
39. GLENNER G.G., WONG C.W. (1984b). Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun, 722 : 1131-1135.
40. GOATE A., CHARTIER-HARLIN M.-C., MULLAN M., BROWN J., CRAWFORD F., FIDANI L., GIUFFRA L., HAYNES A., IRVING N., JAMES L., MANT R., NEWTON P., ROOKE K., ROQUES P., TALBOT C., PERICAK-VANCE M., ROSES A., WILLIAMSON R., ROSSOR M., OWEN M., HARDY J. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349 : 704-706.
41. GOEDERT M., JAKES R., SPILLANTINI M.G., HASEGAWA M., SMITH M.J., CROWTHER R.A. (1996). Assembly of microtubule- associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature, 383 : 550-553.
42. GOLDMAN-RAKIC P.S., BROWN R.M. (1981). Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience, 6 : 177-187.
43. GOMEZ-ISLA T., WEST H.L, REBECK G.W., HARR S.D., GROWDON J.H., LOCASCIO J.J., PERLS T.T., LIPSITZ L.A., HYMAN B.T. (1996). Clinical and pathological correlates of apolipoprotein E 4 in Alzheimer disease. Ann Neurol, 39 : 62-70.
44. GRIFFIN J.W., HOFFMAN P.N., CLARK A.W., CARROLL P.T., PRICE D.L. (1978). Slow axonal transport of neurofilament proteins: impairment by ß,ß'-iminodipropionitrile administration. Science, 202 : 633-635.
45. GRIFFIN J.W., CORK L.C., ADAMS R.J., PRICE D.L. (1982). Axonal transport in Hereditary Canine Spinal Muscular Atrophy (HCSMA). J Neuropathol Exp Neurol, 41 : 370.
46. GRIFFIN J.W., FAHNESTOCK K.E., PRICE D.L., CORK L.C. (1983a). Cytoskeletal disorganization induced by local application of ß,ß'-iminodipropionitrile and 2,5-hexanedione. Ann Neurol, 14 : 55-61.
47. GRIFFIN J.W., FAHNESTOCK K.E., PRICE D.L., HOFFMAN P.M. (1983b). Microtubule-neurofilament segregation produced by ß,ß'-iminodipropionitrile: evidence for the association of fast axonal transport with microtubules. J Neurosci, 3 : 557-566.
48. GURNEY M.E. (1994). Mutant mice, Cu,Zn Superoxide dismutase. and motor neuron degeneration. Science, 266 : 1587
49. GURNEY M.E., Pu H., CHIU A.Y., DAL CANTO M.C., POLCHOW C.Y., ALEXANDER D.D., CALIENDO J., HENTATI A., KWON Y.W., DENG H.-X., CHEN W., ZHAI P., SUFIT R.L., SIDDIQUE T. (1994). Motor neuron degeneration in mice that express a human Cu,Zn Superoxide dismutase mutation. Science, 264 : 1772-1775.
50. GURNEY M.E., CUTTINGS F.B., ZHAI P., DOBLE A., TAYLOR C.P., ANDRUS P.K., HALL E.D. (1996). Benefit of vitamin E, riluzole. and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol, 39 : 147-157.
51. HAASS C., HUNG A.Y., SELKOE D.J., TEPLOW D.B. (1994). Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid ß-protein precursor. J Biol Chem, 269 : 17741-17748.
52. HENDERSON C.E., PHILLIPS H.S., POLLOCK R.A., DAVIES A.M., LEMEULLE C., ARMANINI M., SIMPSON L.C., MOFFET B., VANDLEN R.A., KOLIATSOS V.E., ROSENTHAL A. (1994). GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science, 266 : 1062-1064.
53. HIGGINS U.S., HOLTZMAN D.M., RABIN J., MOBLEY W.C., CORDELL B. (1994). Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann Neurol, 35 : 598-607.
54. HIRANO A., KATO S. (1992). In Smith RA (ed.), Fine structural study of sporadic and familial amyotrophic lateral sclerosis, pp. 183-192. Marcel Dekker, New York.
55. HUFFMAN P.N., GRIFFIN J.W., PRICE D.L. (1984). Control of axonal caliber by neurofilament transport. J Cell Biol 99 : 705-714.
56. HUFFMAN P.N., THOMPSON G.W., GRIFFIN J.W., PRICE D.L. (1985). Changes in neurofilament transport coincide temporally with alterations in the caliber of axons in regenerating motor fibers. J Cell Biol, 101 : 1332-1340.
57. HOFFMAN P.N., CLEVELAND D.W., GRIFFIN J.W., LANDES P.W., COWAN N.J., PRICE D.L. (1987). Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci, USA 84 : 3472-3476.
58. HSIAO K., CHAPMAN P., NILSEN S., ECKMAN C., HARIGAYA Y., YOUNKIN S., YANG F, COLE G. (1996). Correlative memory delicts, Aß elevation and amyloid plaques in transgenic mice. Science, 274 : 99-102.
59. HSIAO K.K., SCOTT M., FOSTER D., GROTH D.F., DE ARMOND S.J., PRUSINER S.B. (1990). Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science, 250 : 1587-1590.
60. HSIAO K.K., BORCHELT D.R., OLSON K., JOHANNSDOTTIR R., KITT C., YUNIS W., Xu S., ECKMAN C., YOUNKIN S., PRICE D., IADECOLA C., CLARK H.B., CARLSON G. (1995). Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron, 15 : 1203-1218.
61. HUNTINGTON'S DISEASE COLLABORATIVE RESEARCH GROUP (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72 : 971-983.
62. IWATSUBO T., ODAKA A., SUZUKI N., MIZUSAWA H., NUKINA N., IHARA Y. (1994). Visualization of AR42(43)-positive and AR40-positive senile plaques with end-specific Aß-monoclonal antibodies: evidence that an initially deposited Aß species is Aß1-42(43). Neuron 13 : 45-53.
63. KANG J., LEMAIRE H.-G., UNTEHBECK A., SALBAUM J.M., MASTERS C.L., GRZESCHIK K.-H., MULTHAUP G., BEYREUTHER K., MULLER-HILL B. (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 : 733-736.
64. KITAGUCHI N., TAKAHASHI Y., TOKUSHIMA Y., SHIOJIRI S., ITO H. (1988). Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331 : 530-532.
65. KITT C.A., PRICE D.L., STRUBLE R.G., CORK L.C., WAINER B.H., BECHER M.W., MOBLEY W.C. (1984). Evidence for cholinergic neurites in senile plaques. Science 226 : 1443-1445.
66. KITTUR S.D., HOH J.H., KAWAS C.H., HAYWARD G.S., ENDO H., ADLER W.H. (1992). A molecular hybridization study for the presence of herpes simplex, cytomegalovirus and Epstein-Barr virus in brain and blood of Alzheimer's disease patients. Arch Gerontol Geriatr, 15 : 35-41.
67. KOLIATSOS V.E., CLATTERBUCK R.E., WINSLOW J.W., CAYOUETTE M.H., PRICE D.L. (1993). Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron, 10 : 359-367.
68. KOLIATSOS V.E., CAYOUETTE M.H., BERKEMEIER L.R., CLATTERBUCK R.E., PRICE D.L, ROSENTHAL A. (1994a). Neurotrophin 4/5 is a trophic factor for mammalian facial motor neurons. Proc Natl Acad Sci USA, 91 : 3304-3308.
69. KOLIATSOS V.E., PRICE W.L., PARDO C.A., PRICE D.L. (1994b). Ventral root avulsion: an experimental model of death of adult motor neurons. J Comp Neurol, 342 : 35-44.
70. KOLIATSOS V.E., PRICE D.L. (1996). Axotomy as an experimental model of neuronal injury and cell death. Brain Pathol, 6 : 447-465.
71. Koo E.H., SISODIA S.S., ARCHER D.R., MARTIN L.J., WEIDEMANN A., BEYREUTHER K., FISCHER P., MASTERS C.L., PRICE D.L. (1990). Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA, 87 : 1561-1565.
72. Koo E.H., SQUAZZO S.L. (1994). Evidence that production and release of amyloid ß-protein involves the endocytic pathway. J Biol Chem, 269 : 17386-17389.
73. KOSHY B., MATILLA T., BURRIGHT E.N., MERRY D.E., FISCHBECK K.H., ORR H.T., ZOGHBI H.Y. (1996). Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 5 : 1311-1318.
74. KREUTZBERG G.W. (1986). In May M (ed.), Neurobiology of regeneration and degeneration, pp. 75-83. Thieme, New York.
75. KREUTZBERG G.W. (1995). In Waxman SG, Kocsis JD, and Stys PK (eds.), Reaction of the neuronal cell body to axonal damage, pp. 355-374. Oxford University Press, New York.
76. KUNCL R.W., CRAWFORD T.O., ROTHSTEIN J.D., DRACHMAN D.B. (1992). In Asbury AK, McKhann GM, and McDonald WI (eds.), Motor neuron diseases, pp. 1179-1208. W.B. Saunders, Philadelphia.
77. LA FERU F.M., TINKLE B.T., BIEBERICH C.J., HAUDENSCHILD C.C., JAY G. (1995). The Alzheimer's Aß peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genetics, 9 : 21-30.
78. LEE M.K., MARSZALEK J.R., CLEVELAND D.W. (1994). A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron, 13 : 975-988.
79. LEE M.K., SLUNT H.H., MARTIN L.J., THINAKARAN G., KIM G., GANDY S.E., SEEGER M., Koo E., PRICE D.L., SISODIA S.S. (1996). Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci, 16 : 7513-7525.
80. LEE M.K., CLEVELAND D.W. (1996). Neuronal intermediate filaments. Annu Rev Neurosci, 19 : 187-217.
81. LEVITAN D., GREENWALD I. (1995). Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature, 377 : 351-354.
82. LEVY-LAHAD E., WASCO W., POORKAJ P., ROMANO D.M., OSHIMA J., PETTINGELL W.H., Yu C.-E., JONDHO P.D., SCHMIDT S.D., WANG K., CROWLEY A.C., Fu Y.-H., GUENETTE S.Y., GALAS D., NEMENS E., WIJSMAN E.M., BIRD T.D., SCHELLENBERG G.D., TANZI R.E. (1995a). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science, 269 : 973-977.
83. LEVY-LAHAD E., WIJSMAN E.M., NEMENS E., ANDERSON L., GODDARD K.A.B., WEBER J.L., BIRD T.D., SCHELLENBERG G.D. (1995b). A familial Alzheimer's disease locus on chromosome 1. Science, 269 : 970-973.
84. Li J., MAJ., POTTER H. (1995). Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3. Proc Natl Acad Sci, USA 92 : 12180-12184.
85. LORENZ M.D., CORK L.C., GRIFFIN J.W., ADAMS R.J., PRICE D.L. (1979). Hereditary spinal muscular atrophy in Brittany spaniels: clinical manifestations. J Am Vet Med Assoc 175 : 833-839.
86. MARTIN L.J., SISODIA S.S., Koo E.H., CORK L.C., DELLOVADE T.L., WEIDEMANN A., BEYREUTHER K., MASTERS C., PRICE D.L. (1991). Amyloid precursor protein in aged nonhuman primates. Proc Natl Acad Sci, USA 88 : 1461-1465.
87. MASLIAH E., SISK A., MALLORY M., MUCKE L., SCHENK D., GAMES D. (1996). Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F ß-amyloid precursor protein and Alzheimer's disease. J Neurosci, 16 : 5795-5811.
88. MASTERS C.L., MULTHAUP G., SIMMS G., POTTGIESSER J., MARTINS R.N., BEYREUTHER K. (1985). Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J, 4 : 2757-2763.
89. MATTSON M.P., RYDEL R.E. (1996). Amyloid ox-tox transducers. Nature, 382 : 674-675.
90. MCKHANN G., DRACHMAN D., FOLSTEIN M., KATZMAN R., PRICE D., STADLAN E.M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34 : 939-944.
91. MORRISON B.M., GORDON J.W., RIPPS M.E., MORRISON J.H. (1996). Quantitative immunocytochemical analysis of the spinal cord in G86R Superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability. J Comp Neurol, 373 : 619-631.
92. MOURELATOS Z., GONATAS N.K., STIEBER A., GURNEY M.E., DALCANTO M.C. (1996). The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn Superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci, USA 93 : 5472-5477.
93. MULLAN M, CRAWFORD F., AXELMAN K., HOULDEN H., LILLIUS L., WINBLAD B., LANNFELT L. (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of ß-amyloid. Nature Genetics, 1 : 345-347.
94. NISHIYAMA K., KWAK S., MURAYAMA S., WATANABE M., GOTO J., ASAYAMA K., KANAZAWA I. (1995). Increased Cu/Zn Superoxide dismutase-like immunoreactivity in the swollen axons of rats intoxicated chronically with ß.ß'-iminodipropionitrile. Neurosci Lett, 194 : 205-208.
95. OPPENHEIMER D.R., ESIRI M.M. (1992). In Adams JH and Duchen LW (eds.), Diseases of the basal ganglia, cerebellum and motor neurons, pp. 988-1045. Oxford University Press, New York.
96. ORR H.T., CHUNG M.-Y., BANFI S., KWIATKOWSKI T.J., JR., SERVADIO A., BEAUDET A.L., MCCALL A.E., DUVICK L.A., RANUM L.P.W., ZOGHBI H.Y. (1993). Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genetics, 4 : 221-226.
97. PENNICA D., ARCE V., SWANSON T.A., VEJSADA R., POLLOCK R.A., ARMANINI M., DUDLEY K., PHILLIPS H.S., ROSENTHAL A., KATO A.C., HENDERSON C.E. (1996). Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron, 17 : 63-74.
98. PIKE C.J., BURDICK D., WALENCEWICZ A.J., GLABE C.G., COTMAN C.W. (1993). Neurodegeneration induced by ß-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci, 13 : 1676-1687.
99. PRESTY S.K., BACHEVALIER J., WALKER L.C., STRUBLE R.G., PRICE D.L., MISHKIN M., CORK L.C. (1987). Age differences in recognition memory of the rhesus monkey (Macaca mulatta). Neurobiol Aging, 8 : 435-440.
100. PRICE D.L., GRIFFIN J.W., HUFFMAN P.M., CORK L.C., SPENCER P.S. (1984). In Dyck PJ, Thomas PK, Lambert EH, and Bunge R (eds.), The response of motor neurons to injury and disease, pp. 732-759. W.B. Saunders, Philadelphia.
101. PRICE D.L., KAWAS C.H., SISOOIA S.S. (1996). In Kandel ER, Schwartz JH, and Jessell TM (eds.), Aging of the brain and dementia of the Alzheimer's type, Elsevier, New York.
102. PRICE D.L., SISODIA S.S. (1994). Cellular and molecular biology of Alzheimer's disease and animal models. Annu Rev Med, 45 : 435-446.
103. RABIZADEH S., BUTLER GRALLA E., BORCHELT D.R., GWINN R., SELVERSTONE VALENTINE J., SISODIA S., WONG P., LEE M., HAHN H., BREDESEN D.E. (1995). Mutations associated with amyotrophic lateral sclerosis convert Superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci, USA 92 : 3024-3028.
104. REAUME A.G., ELLIOTT J.L., HOFFMAN E.K., KOWALL N.W., FERRANTE R.J., SIWEK D.F., WILCOX H.M., FLOOD D.G., BEAL M.F., BROWN R.H., JR., SCOTT R.W., SNIDER W.D. (1996). Motor neurons in Cu/Zn Superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics, 13 : 43-47.
105. RIPPS M.E., HUNTLEY G.W., HOF P.R., MORRISON J.H., GORDON J.W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci, USA 92 : 689-693.
106. ROGAEV E.I., SHERRINGTON R., ROGAEVA E.A., LEVESQUE G., IKEDA M., LIANG Y., CHI H., LIN C., HOLMAN K., TSUDA T., MAR L., SOPBI S., NACMIAS B., PIACENTINI S., AMADUCCI L., CHUMAKOV I., COHEN D., LANNFELT L., FRASER P.E., ROMMENS J.M., ST GEORGE-HYSLOP P.H. (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 376 : 775-778.
107. ROSEN D.R., SIDDIQUE T., PATTERSON D., FIGLEWICZ D.A., SAPP P., HENTATI A., DONALDSON D., GOTO J., O'REGAN J.P., DENG H.-X., RAHMANI Z., KRIZUS A., MCKENNA-YASEK D., CAYABYAB A., GASTON S.M., BERGER R., TANZI R.E., HALPERIN J.J., HERZFELDT B., VAN DEN BERGH R., HUNG W.-Y., BIRD T., DENG G., MULDEH D.W., SMYTH C., LAING N.G., SORIANO E., PERICAK-VANCE M.A., HAINES J., ROULEAU G.A., GUSELLA J.S., HORVITZ H.R., BROWN R.H., Jr. (1993). Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362 : 59-62.
108. ROSES A.D. (1995). Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol, 38 : 6-14.
109. ROWLAND L.P. (1994). In Calne DB (ed.), Natural history and clinical features of amyotrophic lateral sclerosis and related motor neuron diseases, pp. 507-521. W.B. Saunders, Philadelphia.
110. SACK G.H., JR., CORK L.C., MORRIS J.M., GRIFFIN J.W., PRICE D.L. (1984). Autosomal dominant inheritance of Hereditary Canine Spinal Muscular Atrophy. Ann Neurol, 15 : 369-373.
111. SCHELLENBERG G.D. (1995). Progress in Alzheimer's disease genetics. Curr Opin Neurol 8 : 262-267.
112. SCHEUNER D., ECKMAN C., JENSEN M., SONG X., CITRON M., SUZUKI N., BIRD T.D., HARDY J., HUTTON M., KUKULL W., LARSON E., LEVY-LAHAD E., VIITAMEN M., PESKIND E., POORKAJ P., SCHELLENBERG G., TANZI R., WASCO W., LANMFELT L., SELKOE D., YOUNKIN S. (1996). Secreted amyloid ß-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med, 2 : 864-852.
113. SCHMECHEL D.E., SAUNDERS A.M., STRITTMATTER W.J., CRAIN B.J., HULETTE C.M., Joo S.H., PERICAK-VANCE M.A., GOLDGABER D., ROSES A.D. (1993). Increased amyloid ß-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci, USA 90 : 9649-9653.
114. SELKOE D.J., BELL D.S., PODLISNY M.B., PRICE D.L., CORK L.C. (1987). Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science, 235 : 873-877.
115. SENDTNER M., KREUTZBERG G.W., THOENEN H. (1990). Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature, 345 : 440-441.
116. SENDTNER M., HOLTMANN B., KOLBECK R., THOENEN H., BARDE Y.-A. (1992). Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature, 360 : 757-759.
117. SHARP A.H., ROSS C.A. (1996). Neurobiology of Huntington's disease. Neurobiol Dis, 3 : 3-15.
118. SHERHINGTON R., ROGAEV E.I., LIANG Y., ROGAEVA E.A., LEVESQUE G., IKEDA M., CHI H., LIN C., Li G., HOLMAN K., TSUDA T., MAR L., FONCIN J.-R, BRUNI A.C., MONTESI M.P., SORBI S., RAINERO I., PINESSI L., NEE L., CHUMAKOV I., POLLEN D., BROOKES A., SANSEAU P., POLINSKY R.J., WASCO W., DA SILVA H.A.R., HAINES J.L., PERICAK-VANCE M.A., TANZI R.E., ROSES A.D., FRASER P.E., ROMMENS J.M., ST GEORGE-HYSLOP P.H. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375 : 754-760.
119. SIDDIQUE T., NUHAWAN D., HENTATI A. (1996). Molecular genetic basis of familial ALS. Neurology, 47 : S27-S35.
120. SISODIA S.S., Koo E.H., BEYREUTHER K., UNTERBECK A., PRICE D.L. (1990). Evidence that ß-amyloid protein in Alzheimer's disease is not derived by normal processing. Science, 248 : 492-495.
121. SMALE G., NICHOLS N.R., BRADY D.R., FINCH C.E., HORTON W.E., Jr. (1995). Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol, 133 : 225-230.
122. SNIDER W.D., ELLIOTT J.L., YAN Q. (1992). Axotomy-induced neuronal death during development. J Neurobiol, 23 : 1231-1246.
123. ST GEORGE-HYSLOP P.H., HAINES P., ROGAEV E., MORTILLA M., VAULA G., PERICAK-VANCE M., FONCIN J.-F., MONTESI M., BRUNI A., SORBI S., RAINERO I., PINESSI L., POLLEN D., POLINSKY R., NEE L., KENNEDY J., MACCIARDI F., ROGAEVA E., LIANG Y, ALEXANDROVA N., LUKIW W., SCHLUMPF K., TANZI R., TSUDA T, FARRER L., CANTU J.-M., DUARA R., AMADUCCI L., BERGAMINI L, GUSELLA J., ROSES A., CRAPPER MCLACHLAN D. (1992). Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genetics, 2 : 330-334.
124. STRUBLE R.G., CORK L.C., WHITEHOUSE P.J., PRICE D.L. (1982). Cholinergic innervation in neuritic plaques. Science, 216 : 413-415.
125. Su J.H., ANDERSON A.J., CUMMINGS B.J., COTMAN C.W. (1994). Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport, 5 : 2529-2533.
126. SUZUKI N., CHEUNG T.T., CAI X.-D., ODAKA A., OTVOS L., JR., ECKMAN C., GOLDE I.E., YOUNKIN S.G. (1994). An increased percentage of long amyloid ß protein secreted by familial amyloid ß protein precursor (BAPP717) mutants. Science, 264 : 1336-1340.
127. THINAKARAN G., BORCHELT D.R., LEE M.K., SLUNT H.H., SPITZER L., KIM G., RATOVITSKI T., DAVENPORT F., NOROSTEDT C., SEEGER M., HARDY J., LEVEY A.I., GANDY S.E., JENKINS N., COPELAND N., PRICE D.L., SISODIA S.S. (1996a). Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron, 17 : 181-190.
128. THINAKARAN G., TEPLOW D.B., SIMAN R., GREENBERG B., SISODIA S.S. (1996b). Metabolism of the "Swedish" APP variant in Neuro2A (N2a) cells: evidence that cleavage at the "ß-secretase" site occurs in the Golgi apparatus. J Biol Chem, 271 : 9390-9397.
129. TIGGES J., GORDON T.P., MCCLURE H.M., HALL E.G., PETERS A. (1988). Survival rate and life span of rhesus monkeys at the Yerkes Regional Primate Research Center. Am J Primatol, 15 : 263-273.
130. TRONCOSO J.C., SUKHOV R.R., KAWAS C.H., KOLIATSOS V.E. (1996). In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. J Neuropathol Exp Neurol, 55 : 1134-1142.
131. Tu P.-H., RAJU P., ROBINSON K.A., GURNEY M.E., TROJANOWSKI J.Q., LEE V.M.-Y. (1996). Transgenic mice carrying a human mutant Superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci, USA 93 : 3155-3160.
132. WAGMAN I.H., LOEFFLER J.R., MCMILLAN J.A. (1975). Relationship between growth of brain and skull of Macaca mulatta and its importance for the stereotaxic technique. Brain Behav Evol, 12 : 116-134.
133. WAGSTER M.V., WHITEHOUSE P.J., WALKER L.C., KELLAR K.J., PRICE D.L. (1990). Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey. J Neurosci, 10 : 2879-2885.
134. WEISGRABER K.H., PITAS R.E., MAHLEY R.W. (1994). Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E. Curr Opin Struct Biol, 4 : 507-515.
135. WENK G.L., PIERCE D.J., STRUBLE R.G., PRICE D.L., CORK L.C. (1989). Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol Aging, 10 : 11-19.
136. WIEDAU-PAZOS M., GOTO J.J., RABIZADEH S., GRALLA E.B., ROE J.A., LEE M.K., VALENTINE J.S., BREDESEN D.E. (1996). Altered reactivity of Superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271 : 515-518.
137. WILCOX B.J., APPLEGATE M.D., PORTERA-CAILLIAU C., KOLIATSOS V.E. (1995). Nerve growth factor prevents apoptotic cell death in injured central cholinergic neurons. J Comp Neurol, 359 : 573-585.
138. WISNIEWSKI H.M., TERRY R.D. (1973a). Morphology of the aging brain, human and animal. Prog Brain Res, 40 : 167-186.
139. WISNIEWSKI H.M., TERRY R.D. (1973b). In Zimmerman HM (ed.), Reexamination of the pathogeneisis of the senile plaque, pp. 1-26. Grune & Stratton, New York.
140. WISNIEWSKI T., GHISO J., FRANGIONE B. (1991). Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun, 179 : 1247-1254.
141. WONG P.C., MARSZALEK J., CRAWFORD TO., Xu Z., HSIEH S.-T, GRIFFIN J.W., CLEVELAND D.W. (1995a). Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons. J Cell Biol, 130 : 1413-1422.
142. WONG P.C., PARDO C.A., BORCHELT D.R., LEE M.K., COPELAND N.G., JENKINS N.A., SISODIA S.S., CLEVELAND D.W., PRICE D.L. (1995b). An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14 : 1105-1116.
143. Xu Z., CORK L.C., GRIFFIN J.W., CLEVELAND D.W. (1993). Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell, 73 : 23-33.
144. YAN Q., MATHESON C., LOPEZ O.T. (1995). In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature, 373 : 341-344.
145. YANKNER B.A. (1996). Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron, 16 : 921-932.